Literature DB >> 11841609

In vivo gene transfer to kidney by lentiviral vector.

G Luca Gusella1, Elena Fedorova, Daniele Marras, Paul E Klotman, Mary E Klotman.   

Abstract

BACKGROUND: The growing understanding of the molecular basis of renal diseases makes the development of gene therapy for kidney disorders a potential treatment alternative. Work aimed at determining the feasibility and the efficiency of gene transfer to the kidney using different viral and nonviral transduction systems is a necessary component to understanding the full potential. Lentiviral vectors have been shown to transduce stably different tissues and cell types that are refractory to other gene transfer approaches. To date, the potential of lentiviral vectors to transfer genes in kidney has not been investigated. The scope of this work was to analyze the efficiencies of in vivo transduction of kidney by a lentiviral vector.
METHODS: A pseudotyped lentiviral vector carrying the gene for the enhanced green fluorescent protein (EGFP) was delivered into one kidney of experimental mice by retrograde infusion through the ureter. The presence of the virus and the expression of the reporter protein were monitored over time.
RESULTS: Both viral DNA and EGFP expression were measurable in the kidney infused with the lentiviral vector but not in the contralateral kidney. Protein expression was detected by immunostaining, as EGFP fluorescence was masked by the high background fluorescence of the kidney. Expression of EGFP persisted for the entire two-month duration of the experiments.
CONCLUSIONS: Lentiviral vectors can effectively deliver exogenous genes to the kidney in vivo, resulting in persistent expression of the introduced gene.

Entities:  

Mesh:

Year:  2002        PMID: 11841609     DOI: 10.1046/j.1523-1755.2002.0610s1032.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

1.  SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion.

Authors:  Tao Zeng; Xiaolu Duan; Wei Zhu; Yang Liu; Wenqi Wu; Guohua Zeng
Journal:  Urolithiasis       Date:  2017-08-03       Impact factor: 3.436

2.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

3.  Selective renal overexpression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice.

Authors:  Minjae Kim; Sang Won Park; Mihwa Kim; Sean W C Chen; William T Gerthoffer; Vivette D D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-19

4.  Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension.

Authors:  Jian Cao; Komal Sodhi; Kazuyoshi Inoue; John Quilley; Rita Rezzani; Luigi Rodella; Luca Vanella; Lucrezia Germinario; David E Stec; Nader G Abraham; Attallah Kappas
Journal:  Hum Gene Ther       Date:  2011-01-27       Impact factor: 5.695

5.  Intravital imaging of the kidney.

Authors:  Takashi Hato; Seth Winfree; Pierre C Dagher
Journal:  Methods       Date:  2017-04-12       Impact factor: 3.608

6.  Kidney-specific reconstitution of the A1 adenosine receptor in A1 adenosine receptor knockout mice reduces renal ischemia-reperfusion injury.

Authors:  Minjae Kim; Sean W C Chen; Sang Won Park; Mihwa Kim; Vivette D D'Agati; Jay Yang; H Thomas Lee
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

7.  A minimally invasive, lentiviral based method for the rapid and sustained genetic manipulation of renal tubules.

Authors:  Judit Espana-Agusti; David A Tuveson; David J Adams; Athena Matakidou
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

8.  High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis.

Authors:  Xingbo Xu; Xiaoying Tan; Björn Tampe; Tim Wilhelmi; Melanie S Hulshoff; Shoji Saito; Tobias Moser; Raghu Kalluri; Gerd Hasenfuss; Elisabeth M Zeisberg; Michael Zeisberg
Journal:  Nat Commun       Date:  2018-08-29       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.